Evidence map›Paper›PMID 17666527›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Repression of Six3 by a corepressor regulates rhodopsin expression.

Bramanandam Manavathi, Shaohua Peng, Suresh K Rayala, Amjad H Talukder, Minhua H Wang, Rui-An Wang, Seetharaman Balasenthil, Neeraj Agarwal, Laura J Frishman, Rakesh Kumar

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 65 citations in OpenAlex.

  1. Variant-to-gene mapping identifiesbioRxiv : the preprint server for biology · 2026
    Article
  2. SIX3 as a Regulator of Development and Disease.Journal of developmental biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The nucleosome remodeling and deacetylase complex in development and disease.Translational research : the journal of laboratory and clinical medicine · 2015
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Bramanandam ManavathiDepartment of Molecular and Cellular Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Shaohua Peng
Suresh K Rayala
Amjad H Talukder
Minhua H Wang
Rui-An Wang
Seetharaman Balasenthil
Neeraj Agarwal
Laura J Frishman
Rakesh Kumar
Harvard University · USUniversity of Houston · USBaylor College of Medicine · USUniversity of North Texas Health Science Center · US

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI VALLABH E DAS · 1988 to 2026
$16.4M
Role of Metastatic Tumor Antigen-1 in Mammary GlandR01CA098823 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KUMAR, RAKESH · 2003 to 2013
$3.1M
PROXIMAL RETINAL RESPONSES AND THE ERGR01EY006671 · NEI · UNIVERSITY OF HOUSTON · PI FRISHMAN, LAURA J. · 1986 to 2007
$1.7M
NCI NIH HHS CA098823NCI NIH HHS R01 CA098823NEI NIH HHS P30 EY007551NEI NIH HHS R01 EY006671
6 · The paper itself

Abstract

Here, we provide gain-of-function, loss-of function, and molecular evidence supporting genetic interactions between metastasis associated protein 1 (MTA1) and Six3 and between Six3 and rhodopsin. We discovered that MTA1 physically interacts with the Six3 chromatin in a histone deacetylase-dependent manner, leading to transcriptional suppression of the Six3 gene. MTA1 is also a Six3-interacting corepressor that contributes to a self-negative regulation of Six3 transcription by Six3. In contrast, deletion of the MTA1 alleles in murine embryonic fibroblasts or its knockdown in rat retinal ganglion cells stimulates Six3 expression. MTA1 inactivation in the MTA1-null mice results in an elevated Six3 level and proliferation of the retina cells with no obvious abnormities in eye formation. However, unexpectedly, we discovered an enhanced recruitment of Six3 to the rhodopsin chromatin in retina from the MTA1-null mice; Six3's homeodomain interacts with specific DNA elements in the rhodopsin promoter to stimulate its transcription, resulting in increased rhodopsin expression. Further, in holoprosencephaly patients, Six3 protein with a naturally occurring deletion mutation in the helix 3 of the homeodomain does not bind to rhodopsin DNA or stimulate rhodopsin transcription, implying a potential defective rhodopsin pathway in the affected holoprosencephaly patients. Further Six3 cooperates with Crx or NRL in stimulating transcription from the rhodopsin-luc. These findings reveal a previously unrecognized role for the MTA1 as an upstream modifier of Six3 and indicate that Six3 is a direct stimulator of rhodopsin expression, thus revealing a putative role for the MTA1/Six3/rhodopsin pathway in vertebrate eye.

Indexed as

AnimalsEye ProteinsGene Expression RegulationHistone DeacetylasesHomeobox Protein SIX3Homeodomain ProteinsHumansMiceMice, Inbred C57BLNerve Tissue ProteinsPromoter Regions, GeneticRepressor ProteinsRhodopsinTrans-ActivatorsEye ProteinsHistone DeacetylasesHomeobox Protein SIX3Homeodomain ProteinsMTA1 protein, humanNerve Tissue ProteinsRepressor ProteinsRhodopsinTrans-Activators

Identifiers

PMID17666527
PMCPMC1941821
OpenAlexW2161903432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.